Provides laboratory medicine/pathology services. Offers diagnostic imaging/radiology services, including MRI, CT, and X-ray. Now — the numbers.
This is an established company with proven profits.
No real growth (4% a year).
The gap is $3.7B. In times of high interest rates, a gap like that can squeeze a company.
The market pays 15.8× for every dollar of annual profit — around what a business like this usually costs.
Analysts' average target sits 121% above today's price.
The stock trades 60% below its peak. The market has trimmed its expectations for the company.
Our checks did not surface a specific strength to highlight here.
Getting in and out without moving the price could prove difficult.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the revenue breakdown.